Vertex Announces Upcoming Presentation at the J.P. Morgan Healthcare Conference & Date of Fourth Quarter & Full Year 2016 Fin...
January 04 2017 - 4:01PM
Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today
announced that it will webcast its corporate presentation at the
35th Annual J.P. Morgan Healthcare Conference on Monday, January 9
at 12:30 p.m. ET (9:30 a.m. PT). The audio portion of management’s
remarks can be accessed live through Vertex’s website at
www.vrtx.com in the “Investors” section under the “Events and
Presentations” page.
In addition, the company announced today that it will report its
fourth quarter and full year 2016 financial results on Wednesday,
January 25 after the markets close. In conjunction with the
announcement, management will host a conference call that day at
4:30 p.m. ET. To participate in the conference call, please dial
(866) 501-1537 (U.S.) or +1 (720) 545-0001 (International). The
call will also be available as a live and archived webcast on
Vertex’s website.
About Vertex
Vertex is a global biotechnology company that aims to discover,
develop and commercialize innovative medicines so people with
serious diseases can lead better lives. In addition to our clinical
development programs focused on cystic fibrosis, Vertex has more
than a dozen ongoing research programs aimed at other serious and
life-threatening diseases.
Founded in 1989 in Cambridge, Mass., Vertex today has research
and development sites and commercial offices in the United States,
Europe, Canada and Australia. For seven years in a row, Science
magazine has named Vertex one of its Top Employers in the life
sciences. For additional information and the latest updates from
the company, please visit www.vrtx.com.
(VRTX-WEB)
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170104006393/en/
Vertex Pharmaceuticals
IncorporatedInvestors:Michael Partridge,
617-341-6108orEric Rojas, 617-961-7205orZach Barber,
617-341-6470
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Apr 2024 to May 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From May 2023 to May 2024